This story originally published on May 6.
Australian fluorescence firm, Gelcompany this week said that Yale University has adopted its High Performance Electrophoresis FlatTop Tower system, as take-up of the instrument ramps up.
Terence Wu, director of Yale University's W.M. Keck Foundation Biotechnology Resource Laboratory will be using the instrument for his electrophoresis workflow, Gelcompany said in a statement.
The platform was launched in September 2009 and in the past two months has been adopted by influential proteomics researchers, including Friedrich Lottspeich, the head of the Protein Analysis Group within Max Planck-Institute of Biochemistry, and Denis Hochstrasser, vice dean of the faculty of medicine, chairman of the department of genetics and laboratory medicine at Geneva University and University Hospital.
In March, Shareef Antar, chief research scientist in the proteomics core lab with the biosciences and bioengineering department at King Abdullah University of Science and Technology in Saudi Arabia purchased three systems.
According to Gelcompany, the HPE system improves resolution and reproducibility in 1D and 2D gel separations and can detect up to 15 percent more protein spots than other systems because it uses thinner cast-gels and has a more efficient cooling system with higher electric field strength.
The adoption of the HPE system by Yale represents the instrument's debut in the US market. In November, Gelcompany appointed Protea Biosciences as its non-exclusive sales, marketing, and distribution partner for the key North American market.
This week, Gelcompany called the Yale placement "positive confirmation" of the Protea collaboration.
"Not only is the HPE system easier to operate than the traditional systems, but in addition is substantially faster in total operating time, yields higher overall spot resolution, and offers improved reproducibility," Wu said.